Indaptus Therapeutics, Inc. (INDP)
3.50
+0.41
(+13.27%)
USD |
NASDAQ |
Sep 22, 12:05
Indaptus Therapeutics Price to Book Value : 41.01 for Sept. 22, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 36.20 |
| September 18, 2026 | 41.59 |
| September 17, 2026 | 46.05 |
| September 16, 2026 | 37.61 |
| September 15, 2026 | 42.65 |
| September 14, 2026 | 36.79 |
| September 11, 2026 | 32.45 |
| September 10, 2026 | 29.99 |
| September 09, 2026 | 24.37 |
| September 08, 2026 | 21.68 |
| September 04, 2026 | 14.29 |
| September 03, 2026 | 13.59 |
| September 02, 2026 | 13.71 |
| September 01, 2026 | 13.24 |
| August 31, 2026 | 13.42 |
| August 28, 2026 | 13.36 |
| August 27, 2026 | 13.59 |
| August 26, 2026 | 13.36 |
| August 25, 2026 | 12.83 |
| August 24, 2026 | 13.59 |
| August 21, 2026 | 15.11 |
| August 20, 2026 | 16.17 |
| August 19, 2026 | 11.01 |
| August 18, 2026 | 10.97 |
| August 17, 2026 | 11.72 |
| Date | Value |
|---|---|
| August 14, 2026 | 12.54 |
| August 13, 2026 | 12.42 |
| August 12, 2026 | 11.95 |
| August 11, 2026 | 13.94 |
| August 10, 2026 | 13.94 |
| August 07, 2026 | 13.83 |
| August 06, 2026 | 14.65 |
| August 05, 2026 | 15.58 |
| August 04, 2026 | 15.93 |
| August 03, 2026 | 15.35 |
| July 31, 2026 | 15.11 |
| July 30, 2026 | 16.87 |
| July 29, 2026 | 21.32 |
| July 28, 2026 | 20.27 |
| July 27, 2026 | 23.90 |
| July 24, 2026 | 30.58 |
| July 23, 2026 | 32.45 |
| July 22, 2026 | 30.99 |
| July 21, 2026 | 29.53 |
| July 20, 2026 | 28.82 |
| July 17, 2026 | 29.64 |
| July 16, 2026 | 29.64 |
| July 15, 2026 | 33.04 |
| July 14, 2026 | 30.81 |
| July 13, 2026 | 30.81 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.508 |
| Alnylam Pharmaceuticals, Inc. | 25.05 |
| Anika Therapeutics, Inc. | 2.035 |
| Savara, Inc. | 7.764 |
| Vericel Corp. | 5.523 |
Price to Book Value Related Metrics
| Price | 3.50 |
| Earnings Yield | -199.3% |
| Market Cap | 466.35M |